1. Home
  2. HST vs MEDP Comparison

HST vs MEDP Comparison

Compare HST & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Host Hotels & Resorts Inc.

HST

Host Hotels & Resorts Inc.

HOLD

Current Price

$21.20

Market Cap

13.1B

Sector

Real Estate

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$419.26

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HST
MEDP
Founded
1927
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
11.7B
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
HST
MEDP
Price
$21.20
$419.26
Analyst Decision
Buy
Hold
Analyst Count
14
12
Target Price
$20.75
$473.17
AVG Volume (30 Days)
7.4M
455.2K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
4.51%
N/A
EPS Growth
11.11
20.98
EPS
1.10
4.28
Revenue
$5,387,000,000.00
N/A
Revenue This Year
$0.10
$13.19
Revenue Next Year
$1.09
$7.75
P/E Ratio
$19.23
$98.09
Revenue Growth
N/A
N/A
52 Week Low
$14.37
$284.10
52 Week High
$21.55
$628.92

Technical Indicators

Market Signals
Indicator
HST
MEDP
Relative Strength Index (RSI) 63.47 36.57
Support Level $18.59 $382.68
Resistance Level $21.55 $485.13
Average True Range (ATR) 0.41 17.47
MACD -0.00 -10.02
Stochastic Oscillator 69.04 27.75

Price Performance

Historical Comparison
HST
MEDP

About HST Host Hotels & Resorts Inc.

Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: